Daily News Watch

News Home Page

Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.

Seahorse Bioscience and UAB Partner to Advance Validation of Bioenergetic Health Index for Personalized Medicine

Seahorse Bioscience and the University of Alabama at Birmingham (UAB) have announced that they have entered into a partnership to study the bioenergetic health of cells in cryopreserved blood -- a step that will ultimately produce a first-of-its-kind clinical test of metabolic bioenergetic health. As cutting-edge work is now being done on metabolo-therapeutics, there is a critical need to develop indicators of patients' metabolic status so that a targeted therapeutic approach for each patient can be ...

Posted on: October 31, 2014
Mindray and MedTest Jointly Announce FDA Clearance for the BS-480 Chemistry Analyzer

Mindray and MedTest have received 510(k) clearance from the FDA to market and sell the new Mindray BS-480 Chemistry Analyzer. The Mindray BS-480 Analyzer meets the testing needs of mid-volume laboratories while offering state-of-the-art features commonly found on large volume analyzers.The BS-480 Analyzer produces 400 photometric test results per hour, 240 ISE tests per hour with an overall throughput of 560 tests per hour. Advanced features of the BS-480 analyzer include numerous automatic processes such ...

Posted on: October 30, 2014
Thermo Fisher Scientific Launches New Immunoassay for Specific Detection of Hydrocodone and Major Metabolites

Thermo Fisher Scientific Inc., a leading provider of drugs of abuse testing solutions, has announced the launch of the new Thermo Scientific DRI Hydrocodone/Hydromorphone Assay. The new assay is a homogeneous enzyme immunoassay that specifically detects hydrocodone and major metabolites in human urine at a 300 ng/mL cut-off. The assay utilizes liquid ready-to-use reagents, calibrators and controls, and can be run in qualitative and semi-quantitative modes. The assay has excellent cross-reactivity to the ...

Posted on: October 30, 2014
BioFire Defense, a bioMerieux Company, Gets Fast-track Authorization for FilmArray Ebola Test

BioFire Defense has received emergency use authorization by the FDA for Its FilmArray Ebola test. The test runs on the BioFire FilmArray system, a highly accurate, fast, and easy-to-use PCR molecular diagnostic instrument which is currently used in hundreds of hospitals in the United States. The system delivers test results in one-hour, significantly reducing current testing time and allowing health professionals to make treatment decisions faster. "This EUA and FilmArray test for ...

Posted on: October 29, 2014
Phenogen Sciences Introduces BREVAGenplus Breast Cancer Risk Assessment Test

Phenogen Sciences have announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company's first generation product, BREVAGen. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman's five-year and lifetime risk of developing the disease. The test is ...

Posted on: October 28, 2014
Fasting Blood Biomarker Alpha-Hydroxybutyrate Predicts Risk for Diabetes In New Study

Could a single serum biomarker predict risk for diabetes as accurately as a more complex, hours-long diagnostic procedure? According to researchers at Health Diagnostic Laboratory Inc. (HDL) and the University of Utah, the answer is "yes."  In a newly published study, the scientists found that fasting levels of the serum marker alpha-hydroxybutyrate (a-HB), measured as part of a routine blood draw, could be a valuable clinical surrogate for the oral glucose tolerance test (OGTT).The decades-old OGTT ...

Posted on: October 27, 2014
Merck and TAP Biosystems Chosen as Finalists for "Best Collaboration Award" at BPI 2014

TAP Biosystems (now part of the Sartorius Stedim Biotech Group), a supplier of innovative cell culture and fermentation systems for life science applications, and Merck have been nominated as co-finalists for two awards at the prestigious 2014 BioProcess International (BPI) Awards. The nominations recognize that the ambr250 System, developed as a result of the collaboration, is a major advance in bioprocessing technology.At the BioProcess International Awards, TAP Biosystems and Merck have been selected ...

Posted on: October 26, 2014
Dolomite and Lab on a Chip Launch Productizing Science Competition 2015

Dolomite, a pioneering microfluidics specialist, and Lab on a Chip are challenging entrepreneurial researchers, scientists and engineers to enter the Productizing Science Competition 2015, proposing novel, microfluidics-based concepts with commercial potential.The Productizing Science Competition, jointly organized by Dolomite and Lab on a Chip, aims to bridge the gap between scientific innovation and commercial success by turning early stage technologies into market-leading ...

Posted on: October 24, 2014
Advanced Cell Diagnostics Awarded NCI Grant to Develop Ultrasensitive Diagnostic Test for B-Cell Lymphoma

Advanced Cell Diagnostics, Inc. (ACD), a global technology and market leader in in situ nucleic acid detection for life science research and clinical diagnostics, has been awarded a two-year, $1.4 million grant from National Cancer Institute (NCI) under its SBIR Phase II Program. ACD and its academic partner Cleveland Clinic will use the grant to develop and validate a diagnostic test based on ACD's proprietary RNAscope(R) technology for discriminating various B-cell non-Hodgkin lymphomas (NHLs) from ...

Posted on: October 23, 2014
Diatron Launches Intelligent Walk-away Analyzer at Medica

The Diatron Group, global provider of hematology and clinical chemistry analyzers, will launch its new economic walk-away clinical chemistry analyzer, the P500, at Medica, Dusseldorf, Nov. 12-15.  The new medium throughput system (215 tests/hour on a typical sample mix) is ergonomically designed and user-friendly with a high level of automation that delivers assured result quality. The intuitive windows-based software and smart architecture means the P500 is able to offer many features on an ...

Posted on: October 22, 2014
Rheonix to Automate FFPE Tissue Samples for Next Generation Sequencing

Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been granted patent 8,852,919 "Microfluidic Apparatus, Method, and Applications" for its automated molecular diagnostics system, the EncompassMD.  This recent patent will help researchers and clinicians analyze tissue samples preserved in paraffin more efficiently, at a lower cost and with higher processing throughput.The '919 patent automates a liquid-liquid extraction process that easily removes paraffin from ...

Posted on: October 21, 2014
NovoPath Announces a Standardized HL7 Interface with athenahealth

Committed to meeting a full range of anatomic pathology laboratory needs, NovoPath announces an interface to athenahealth for NovoPath's Anatomic Pathology Laboratory Information System (APLIS). athenahealth, a leading provider of cloud-based services and mobile tools for medical groups and health systems, combines award-winning software, network knowledge and back-office services to take on providers' most onerous work and keep them ahead of change.athenahealth joins NovoPath's growing roster of ...

Posted on: October 20, 2014
Claritas Genomics Launches Next Generation Sequencing Panel to Detect Genetic Causes of Nephrotic Syndrome in Children

Claritas Genomics, a clinical laboratory serving the DNA-based diagnostic testing needs of children's hospitals, announced the availability of a next-generation sequencing assay that investigates 28 genes that represent single-gene causes of pediatric steroid-resistant Nephrotic Syndrome. The assay was developed in collaboration with  a laboratory at Boston Children's Hospital that has been studying the underlying genetic causes of many types of pediatric kidney disorders for several decades.Patrice ...

Posted on: October 19, 2014
Study Shows Children Who Have Had Enterovirus Infection Are 48% More Likely To Have Type 1 Diabetes

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that children who have been infected with enterovirus are 48% more likely to have developed type 1 diabetes. The study is by Tsai Chung-Li, MD, China Medical University, Taiwan, and colleagues."Type 1 diabetes is considered to be caused by complex interaction between genetic susceptibility, the immune system, and environmental factors," say the authors. "Though the cue for genetic ...

Posted on: October 18, 2014
Beckman Coulter Receives FDA Clearance on Power Express High-Speed Automated Sample Processing System

Beckman Coulter has received FDA) 510(k) clearance on its Power Express high-speed automated sample processing system. Designed to meet the needs of the most demanding laboratories, the Power Express processes samples for all core disciplines - chemistry, immunoassay, hematology and coagulation. The Power Express provides the enhanced benefit of connected automation by combining Beckman Coulter's industry-leading AU clinical chemistry system; the UniCel DxI 800 immunoassay system for high-throughput ...

Posted on: October 17, 2014
View Archives